Melhores Terapia alvo para câncer do pulmão médicos em Israel - TOP-4 médicos

O Prof. Merimsky chefia a Unidade de Oncologia de Tecidos Moles e Ósseos no Sourasky Medical Center, com mais de 25 anos de especialização em tratamentos de câncer de pulmão e sarcoma.

• Realizou um Fellowship (formação especializada) em sarcoma no Institut Gustave Roussy em Paris
• Membro do Corpo Docente da ESMO para sarcoma de tecidos moles e ósseos
• Vice-presidente do Comitê de Ética de Sourasky
• Pesquisa publicada sobre imunologia tumoral e terapias direcionadas

O Dr. Ari Raphael lidera pesquisas inovadoras em câncer de pulmão no Tel Aviv Sourasky Medical Center, com foco em perfil genômico e imunoterapia.

• Investigador principal de múltiplos ensaios clínicos sobre tratamentos de CPNC
• Especialista em biópsias líquidas e perfil genômico abrangente
• Membro da IASLC e ESMO, organizações fundamentais na pesquisa do câncer de pulmão
• Moderador do Conselho de Tumores Moleculares da Sociedade Israelense de Câncer de Pulmão
• Beneficiário de bolsa de pesquisa ISCORT e prêmios de ensino

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.